CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities:
Net income (loss)	$ (8,451)	$ 33,344
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	3,521	3,909
Stock-based compensation	12,522	11,790
Restructuring equity modification expense		366
Accretion of discount or amortization of premium on investments	(590)	(67)
Amortization of debt issuance costs	414	407
Deferred tax expense	(93)	(278)
Revaluation of acquisition-related contingent consideration liability		907
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable	(220)	(4,503)
Inventory	896	9,400
Prepaid expenses and other assets	870	1,355
Accounts payable	(6,623)	1,878
Accrued compensation and employee related benefits	(13,401)	(292)
Accrued and other liabilities	405	2,182
Operating lease right-of-use assets	653	614
Operating lease liabilities	(887)	(820)
Deferred revenue	(159)	(52)
Net cash provided by (used in) operating activities	(11,143)	60,140
Investing activities:
Purchases of investments	(25,910)
Proceeds from maturities of investments	49,000	11,248
Purchases of property and equipment	(1,863)	(6,202)
Net cash provided by investing activities	21,227	5,046
Financing activities:
Proceeds from exercise of stock options and employee stock purchase plan	5,847	6,917
Payments of taxes on restricted stock units	(787)
Net cash provided by financing activities	5,060	6,917
Effect of exchange rate changes on cash and cash equivalents	120	(44)
Net increase in cash and cash equivalents	15,264	72,059
Cash and cash equivalents
Beginning of period	46,053	94,793
End of period	61,317	166,852
Supplemental disclosure of cashflow information:
Purchases of property and equipment not yet paid	$ 940	299
Acquisition-related contingent consideration liability		$ 7,087